在FDA不良事件报告系统 (FAERS) 数据库中进行了mepolizumab的现实世界药监测研究
Fan Zou1, Chengyu Zhu1, Siyu Lou1
1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Frontiers in pharmacology
|January 8, 2024
概括
这项研究分析了FDA的数据以确定梅波利祖马布的副作用,发现了198个不良事件,包括新的未在标签上的事件. 现实世界的数据显示,梅波利祖马布不良反应的性别特异性风险和不同发病时间不同.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 现实世界的证据 现实世界的证据
背景情况:
- 梅波利祖马布治疗严重的喘,带有多炎的埃索诺菲尔粒状炎,带有埃索诺菲尔综合征的慢性鼻炎和带有鼻的慢性鼻炎.
- 现有的药物不良反应 (ADR) 数据主要来自临床试验,缺乏广泛的真实世界样本大小.
- 现实世界的安全数据对于全面了解梅波利祖马布的ADR概况至关重要.
研究的目的:
- 通过使用大型现实世界的数据库来评估与mepolizumab相关的不良事件.
- 识别显著不良事件 (AE) 并将其与产品标签进行比较.
- 分析梅波利祖马布诱导的副作用的发病时间和性别特异性模式.
主要方法:
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库的分析.
- 包括18,040份关于梅波利祖马布相关不良事件的报告.
- 应用多个不成比例分析算法来评估AE显著性.
主要成果:
- 鉴定了198种由梅波利祖马布诱导的副作用,包括未在产品标签上列出的新发现.
- 副作用的发病时间中位数为109天,大多数发生在第一个月内.
- 观察到AEs的性别特异性差异,女性经历了更多的消化/神经效应,男性面临住院/死亡的更高风险.
结论:
- 这项研究为mepolizumab的安全性概况提供了宝贵的现实洞察力.
- 这些发现可以优化mepolizumab的临床使用,并通过尽量减少副作用来改善患者的治疗结果.
- 这些药监数据支持改善梅波利祖马布的临床实施和患者安全策略.
更多相关视频
08:58Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
43.0K
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.3K
相关概念视频
01:19Pharmacovigilance
838
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
838
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
301
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
301
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K